Immunic names ex-Genentech executive Erik Lundgren CEO, replacing Daniel Vitt

IMMUNIC INC

IMMUNIC INC

IMUX

0.00
  • Immunic named Erik Lundgren chief executive officer, effective May 22, 2026; employment begins June 1.
  • Lundgren was most recently senior vice president, Commercial Portfolio Organization at Genentech; previously general manager of Roche Czech Republic.
  • He succeeds Daniel Vitt, who will retain responsibility for scientific strategy and portfolio advancement, remaining on the board.
  • Management change comes as the company advances vidofludimus calcium in the phase 3 ENSURE program in relapsing multiple sclerosis.
  • Immunic is also preparing a planned phase 3 program in primary progressive multiple sclerosis, alongside NDA and commercialization preparations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605270630PR_NEWS_USPR_____NY67899) on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.